Inscripta, formerly Muse Biotechnology, is advancing genome engineering and synthetic biology technology (ForgeCraft) which combines computer-aided forward design software package, a proprietary benchtop biofoundry, and custom reagents to enable researchers and production scientists to rapidly explorate the genetic landscape at scale and accelerate their work.

Inscripta, formerly Muse Biotechnology, is advancing genome engineering and synthetic biology technology (ForgeCraft) which combines computer-aided forward design software package, a proprietary benchtop biofoundry, and custom reagents to enable rese...Show all

Company (Alive / Active)

All investors data 7 Investors

• Foresite Capital Management
• Malaysian Life Sciences Capital Fund
• Merieux Developpement
• NanoDimension
• Paladin Capital Group